Brief Research Report

Published on 11 Apr 2023

DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice

in Vaccines and Molecular Therapeutics

Gry Persson
Katherine H. Restori
Julie Hincheli Emdrup
Sophie Schussek
Michael Schantz Klausen
McKayla J. Nicol
Bhuvana Katkere
Birgitte Rønø
Girish Kirimanjeswara
Anders Bundgaard Sørensen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1166546

5,196 views
4 citations

Original Research

Published on 06 Apr 2023

Thyroid function and associated mood changes after COVID-19 vaccines in patients with Hashimoto thyroiditis

in Vaccines and Molecular Therapeutics

Yifei Ma
Jiling Zeng
Yongluo Jiang
Yi-Wei Xu
Youlong Wang
Guanqing Zhong
Nianqi Liu
Yanqi Wang
Zhiying Zhang
Yiming Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1129746

9,433 views
3 citations

Methods

Published on 06 Apr 2023

Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology models

in Vaccines and Molecular Therapeutics

Davide Moi
Bijun Zeng
Simone A. Minnie
Rituparna Bhatt
Jack Wood
David P. Sester
Roberta Mazzieri
Riccardo Dolcetti

Frontiers in Immunology

doi 10.3389/fimmu.2023.1127896

5,000 views
2 citations

Original Research

Published on 06 Apr 2023

H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials

in Vaccines and Molecular Therapeutics

Sheetal Sawant
Sarah Anne Gurley
R. Glenn Overman
Angelina Sharak
Sarah V. Mudrak
Thomas Oguin
Gregory D. Sempowski
Marcella Sarzotti-Kelsoe
Emmanuel B. Walter
Hang Xie

Frontiers in Immunology

doi 10.3389/fimmu.2023.1155880

6,155 views
1 citation

Review

Published on 06 Apr 2023

Syphilis vaccine: challenges, controversies and opportunities

in Vaccines and Molecular Therapeutics

Carlos Ávila-Nieto
Núria Pedreño-López
Oriol Mitjà
Bonaventura Clotet
Julià Blanco
Jorge Carrillo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1126170

16,412 views
16 citations

Original Research

Published on 05 Apr 2023

Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles

in Vaccines and Molecular Therapeutics

Martina Borghi
Alessandra Gallinaro
Maria Franca Pirillo
Andrea Canitano
Zuleika Michelini
Maria Laura De Angelis
Serena Cecchetti
Antonella Tinari
Chiara Falce
Sabrina Mariotti

Frontiers in Immunology

doi 10.3389/fimmu.2023.1147953

3,112 views
3 citations

Mini Review

Published on 05 Apr 2023

Research progress in the development of natural-product-based mucosal vaccine adjuvants

in Vaccines and Molecular Therapeutics

Yingying Gao
Ying Guo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1152855

3,742 views
7 citations

Original Research

Published on 05 Apr 2023

The retrospective study of the metabolic patterns of BCG-vaccination in type-2 diabetic individuals in COVID-19 infection

in Vaccines and Molecular Therapeutics

Najeha R. Anwardeen
Farhan S. Cyprian
Hadi M. Yassine
Asmaa A. Al-Thani
Abdallah M. Abdallah
Mohamed M. Emara
Mohamed A. Elrayess

Frontiers in Immunology

doi 10.3389/fimmu.2023.1146443

2,537 views
2 citations

Review

Published on 31 Mar 2023

Maintenance and recall of memory T cell populations against tuberculosis: Implications for vaccine design

in Vaccines and Molecular Therapeutics

Xin Liu
Haoran Li
Shanshan Li
Jinfeng Yuan
Yu Pang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1100741

4,074 views
8 citations

Original Research

Published on 31 Mar 2023

Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction

in Vaccines and Molecular Therapeutics

Masaud Shah
Ji-Yon Shin
Hyun Goo Woo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1113175

3,970 views
1 citation

Systematic Review

Published on 31 Mar 2023

Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review

in Vaccines and Molecular Therapeutics

Abdulaziz Molham Moglan
Omar A. Albaradie
Fares Fayez Alsayegh
Hussam Mohsen Alharbi
Yahya Marwan Samman
Mohammed M. Jalal
Nizar H. Saeedi
Ahmad Bakur Mahmoud
Almohanad A. Alkayyal

Frontiers in Immunology

doi 10.3389/fimmu.2023.1085940

3,898 views
1 citation

Original Research

Published on 31 Mar 2023

C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

in Vaccines and Molecular Therapeutics

Maria Vono
Beatris Mastelic-Gavillet
Elodie Mohr
Malin Östensson
Josefine Persson
Thorunn A. Olafsdottir
Sylvain Lemeille
David Pejoski
Oliver Hartley
Dennis Christensen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1155200

3,447 views
2 citations

Original Research

Published on 31 Mar 2023

Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients

in Vaccines and Molecular Therapeutics

Nina Körber
Christopher Holzmann-Littig
Gesa Wilkens
Bo-Hung Liao
Maia L. Werz
Louise Platen
Cho-Chin Cheng
Myriam Tellenbach
Verena Kappler
Viktor Lehner

Frontiers in Immunology

doi 10.3389/fimmu.2023.1172477

2,964 views
5 citations

Original Research

Published on 30 Mar 2023

Development of a dual vaccine against East Coast fever and lumpy skin disease

in Vaccines and Molecular Therapeutics

Leah Whittle
Ros Chapman
Nicola Douglass
Mohamed Jaffer
Emmanuel Margolin
Edward Rybicki
Anna-Lise Williamson

Frontiers in Immunology

doi 10.3389/fimmu.2023.1143034

2,762 views
3 citations

Original Research

Published on 30 Mar 2023

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19

in Vaccines and Molecular Therapeutics

Ilias B. Esmagambetov
Ekaterina I. Ryabova
Artem A. Derkaev
Dmitry V. Shcheblyakov
Inna V. Dolzhikova
Irina A. Favorskaya
Daria M. Grousova
Mikhail A. Dovgiy
Vladimir V. Prokofiev
Andrey I. Gosudarev

Frontiers in Immunology

doi 10.3389/fimmu.2023.1129245

2,403 views
9 citations

Perspective

Published on 30 Mar 2023

Repurposing mucosal delivery devices for live attenuated tuberculosis vaccines

in Vaccines and Molecular Therapeutics

Munish Puri
Socorro Miranda-Hernandez
Selvakumar Subbian
Andreas Kupz

Frontiers in Immunology

doi 10.3389/fimmu.2023.1159084

2,338 views

Navigation group

Articles

DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice

Thyroid function and associated mood changes after COVID-19 vaccines in patients with Hashimoto thyroiditis

Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology models

H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials

Syphilis vaccine: challenges, controversies and opportunities

Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles

Research progress in the development of natural-product-based mucosal vaccine adjuvants

The retrospective study of the metabolic patterns of BCG-vaccination in type-2 diabetic individuals in COVID-19 infection

Maintenance and recall of memory T cell populations against tuberculosis: Implications for vaccine design

Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction

Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review

C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients

Development of a dual vaccine against East Coast fever and lumpy skin disease

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19

Repurposing mucosal delivery devices for live attenuated tuberculosis vaccines